CGC
Price
$1.30
Change
-$0.19 (-12.75%)
Updated
Aug 15 closing price
Capitalization
313.9M
82 days until earnings call
HCM
Price
$16.45
Change
+$0.58 (+3.65%)
Updated
Aug 15 closing price
Capitalization
2.73B
89 days until earnings call
Interact to see
Advertisement

CGC vs HCM

Header iconCGC vs HCM Comparison
Open Charts CGC vs HCMBanner chart's image
Canopy Growth
Price$1.30
Change-$0.19 (-12.75%)
Volume$25.44M
Capitalization313.9M
HUTCHMED (China)
Price$16.45
Change+$0.58 (+3.65%)
Volume$34.06K
Capitalization2.73B
CGC vs HCM Comparison Chart in %
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. HCM commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Hold and HCM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (CGC: $1.30 vs. HCM: $16.45)
Brand notoriety: CGC: Notable vs. HCM: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CGC: 177% vs. HCM: 56%
Market capitalization -- CGC: $313.9M vs. HCM: $2.73B
CGC [@Pharmaceuticals: Generic] is valued at $313.9M. HCM’s [@Pharmaceuticals: Generic] market capitalization is $2.73B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileHCM’s FA Score has 0 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • HCM’s FA Score: 0 green, 5 red.
According to our system of comparison, both CGC and HCM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 5 TA indicator(s) are bullish while HCM’s TA Score has 5 bullish TA indicator(s).

  • CGC’s TA Score: 5 bullish, 5 bearish.
  • HCM’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, CGC is a better buy in the short-term than HCM.

Price Growth

CGC (@Pharmaceuticals: Generic) experienced а +4.00% price change this week, while HCM (@Pharmaceuticals: Generic) price change was +9.67% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

CGC is expected to report earnings on Nov 07, 2025.

HCM is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HCM($2.73B) has a higher market cap than CGC($314M). HCM YTD gains are higher at: 14.157 vs. CGC (-52.555). HCM has higher annual earnings (EBITDA): 14.1M vs. CGC (-479.31M). HCM has more cash in the bank: 836M vs. CGC (131M). HCM has less debt than CGC: HCM (89.8M) vs CGC (348M). HCM has higher revenues than CGC: HCM (630M) vs CGC (269M).
CGCHCMCGC / HCM
Capitalization314M2.73B11%
EBITDA-479.31M14.1M-3,399%
Gain YTD-52.55514.157-371%
P/E RatioN/A6.21-
Revenue269M630M43%
Total Cash131M836M16%
Total Debt348M89.8M388%
FUNDAMENTALS RATINGS
CGC vs HCM: Fundamental Ratings
CGC
HCM
OUTLOOK RATING
1..100
1461
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9973
PRICE GROWTH RATING
1..100
5853
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HCM's Valuation (88) in the Pharmaceuticals Major industry is in the same range as CGC (91) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew similarly to CGC’s over the last 12 months.

HCM's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew similarly to CGC’s over the last 12 months.

HCM's SMR Rating (73) in the Pharmaceuticals Major industry is in the same range as CGC (99) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew similarly to CGC’s over the last 12 months.

HCM's Price Growth Rating (53) in the Pharmaceuticals Major industry is in the same range as CGC (58) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew similarly to CGC’s over the last 12 months.

HCM's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCHCM
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 20 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VRREX18.330.10
+0.55%
Virtus Duff & Phelps Real Estate Secs R6
QUASX62.850.05
+0.08%
AB Small Cap Growth A
SZCAX50.57-0.08
-0.16%
DWS Small Cap Core A
JRAIX96.55-0.25
-0.26%
Janus Henderson Research I
BMPEX27.72-0.09
-0.32%
Beck Mack + Oliver Partners

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been loosely correlated with ACB. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if CGC jumps, then ACB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
-12.75%
ACB - CGC
66%
Loosely correlated
-5.75%
TLRY - CGC
61%
Loosely correlated
-12.71%
CRON - CGC
59%
Loosely correlated
-5.95%
OGI - CGC
58%
Loosely correlated
-8.33%
NBIX - CGC
30%
Poorly correlated
+1.21%
More

HCM and

Correlation & Price change

A.I.dvisor tells us that HCM and CGC have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HCM and CGC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCM
1D Price
Change %
HCM100%
+3.65%
CGC - HCM
23%
Poorly correlated
-12.75%
OGI - HCM
22%
Poorly correlated
-8.33%
CRON - HCM
22%
Poorly correlated
-5.95%
AQST - HCM
22%
Poorly correlated
N/A
KNSA - HCM
22%
Poorly correlated
+0.30%
More